Embody vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats Embody overall, scoring 7.7/10 vs 7.3/10. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Embody and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Embody

#38 of 48

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Embody	MEDVi
Our Score	7.3/10	7.7/10
Starting Price	$299/mo	$299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	People who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan	Users who want a low entry price with oral and injectable compounded options
Ranking	#38	#22

Pros & Cons Compared

Embody

Pros

+Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
−Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
−Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
−Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Embody with a score of 7.7/10 vs 7.3/10. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Embody nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review